Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Seer, Inc. | 273,142 | reported | 22 Feb 2024 | tx 4+342,882−12,684 |
| Apimeds Pharmaceuticals US, Inc. | 10,000 | reported | 11 Nov 2025 | tx 3+18,780 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Nov 2025 | GRANT_AWARD | Apimeds Pharmaceuticals US, Inc. | 10,000 | 0.00 USD | deriv |
| 15 Oct 2025 | GRANT_AWARD | Apimeds Pharmaceuticals US, Inc. | 3,000 | 0.00 USD | deriv |
| 16 May 2025 | GRANT_AWARD | Apimeds Pharmaceuticals US, Inc. | 5,780 | 0.00 USD | deriv |
| 06 Feb 2024 | GRANT_AWARD | Seer, Inc. | 123,153 | 0.00 USD | |
| 22 Feb 2024 | SALE | Seer, Inc. | 12,684 | 1.58 USD | |
| 06 Feb 2024 | GRANT_AWARD | Seer, Inc. | 79,729 | 0.00 USD | deriv |
| 06 Feb 2024 | GRANT_AWARD | Seer, Inc. | 140,000 | 0.00 USD | deriv |